Patent classifications
C07D209/88
Organic light-emitting device
An organic light-emitting device including a predetermined host and a thermally activated delayed fluorescence emitter.
TRIARYLAMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE THEREOF
Provided are a triarylamine derivative and an organic electroluminescent device thereof, which relate to the technical field of organic electroluminescence. The triarylamine derivative has a relatively high triplet energy level, high hole mobility, a high refractive index and good film formability and thermal stability and can effectively reduce the driving voltage of the organic electroluminescent device, improve the luminescence efficiency, and extend the service life of the device when applied to the organic electroluminescent device. The triarylamine derivative has a good application effect and a good industrialization prospect in the organic electroluminescent device.
Polymer, coating composition comprising same, and organic light emitting device using same
The present specification relates to a polymer including a unit represented by Chemical Formula 1, a coating composition including the same, and an organic light emitting device formed using the same: ##STR00001##
wherein all the variables are described herein.
Polymer, coating composition comprising same, and organic light emitting device using same
The present specification relates to a polymer including a unit represented by Chemical Formula 1, a coating composition including the same, and an organic light emitting device formed using the same: ##STR00001##
wherein all the variables are described herein.
Tricyclic Modulators of PP2A
Chemical modulators of PP2A, comprising tricyclic sulfonimidamides are disclosed. The compounds are useful in preventing or treating cancer, diabetes, autoimmune disease, solid organ transplant rejection, graft vs host disease, chronic obstructive pulmonary disease (COPD), non-alcoholic fatty liver disease, abdominal aortic aneurysm, chronic liver disease, heart failure, neurodegenerative disease and cardiac hypertrophy. The compounds are of formula (I)
##STR00001##
TREATMENT OF EPILEPTIC CONDITIONS WITH GABAA RECEPTOR MODULATORS
Disclosed herein are GABA.sub.A receptor modulators and compositions comprising GABA.sub.A receptor modulators for treatment of epileptic conditions. Also disclosed herein are methods of treating epileptic conditions in a subject by administering a GABA.sub.A receptor modulators or composition as described herein.
METHOD FOR PREPARING DEUTERATED AROMATIC COMPOUND, AND DEUTERATED REACTIVE COMPOSITION
The present specification relates to a method for producing a deuterated aromatic compound and a deuterated reaction composition.
METHOD FOR PREPARING DEUTERATED AROMATIC COMPOUND, AND DEUTERATED REACTIVE COMPOSITION
The present specification relates to a method for producing a deuterated aromatic compound and a deuterated reaction composition.
Compound for organic electric device, organic electric device using same, and electronic device
Provided is a novel compound capable of improving the luminous efficiency, stability and lifespan of a device, an organic electronic device using the same, and an electronic device.
Compound for organic electric device, organic electric device using same, and electronic device
Provided is a novel compound capable of improving the luminous efficiency, stability and lifespan of a device, an organic electronic device using the same, and an electronic device.